3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
6
Uterine Cervical Neoplasms
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Multiple Myeloma
2
Adenomatous Polyposis Coli
2
Uterine Neoplasms
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Smoldering Multiple Myeloma
1
Sezary Syndrome
1
Radiodermatitis
1
Prostate Cancer Metastatic Castration Resistant
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pain
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Monoclonal Gammopathy of Undetermined Significance
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Head and Neck Neoplasms
1
Gastritis, Atrophic
1
Fatigue
1
Endometrial Neoplasms
1
Communicable Diseases
1
Colorectal Neoplasms
1
Interventions
Docetaxel
1
Curcumin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Prostate Cancer Metastatic Castration Resistant
×
Curcumin
×
Clear all
NCT02095717
2018-07-24
CURTAXEL
Centre Jean Perrin
Phase 2
Terminated
50 enrolled